Frontlight ResearchEarly access
Eosinophilic oesophagitis trials in Netherlands
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleOptimization of Dupilumab Maintenance Dosing in Eosinophilic Esophagitis
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 160
- Run by
- Amsterdam UMC Stichting
See details and how to join2026-526348-11-01 - Phase 1Taking peopleSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of ANB033
- Where
- Amsterdam, Dordrecht, Groningen
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- First Tracks Biotherapeutics Inc.
See details and how to join2024-520409-38-00 - Phase 1/2CompletedA Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).
- Where
- Amsterdam, Rotterdam
- Age
- 18 years to 75 years
- People
- 117 worldwide
- Run by
- Eupraxia Pharmaceuticals Inc.
See details and how to joinNCT05608681 · EU 2024-516689-13-00 - No phaseTaking peopleLocal Clinical and Immunological Responses in Eosinophilic Esophagitis (EoE) Patients, Role of Mucosal Barrier Function and Type II Inflammation
- Where
- Amsterdam
- Age
- 18 years to 75 years
- People
- 56
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07012928 - No phaseTaking peopleAn Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 72
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT05730933